Advanced Cancer
Showing NaN - NaN of 101
Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)
Recruiting
- Metastatic Cancer
- +2 more
- ASP9801
- Pembrolizumab
-
Birmingham, Alabama
- +26 more
Jan 6, 2023
Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)
Not yet recruiting
- Advanced Cancer
- Clear Cell Renal Cell Carcinoma
- 177Lu girentuximab
- +3 more
-
Houston, TexasMD Anderson Cancer Center
Dec 15, 2022
Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)
Completed
- Advanced Cancer
- Dasatinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 21, 2022
Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- +11 more
- KY1044
- KY1044 and atezolizumab
-
New Haven, Connecticut
- +12 more
Nov 3, 2022
Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)
Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)
Active, not recruiting
- Advanced Cancer
- Temsirolimus
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)
Recruiting
- Advanced Cancer
- +7 more
-
Scottsdale, Arizona
- +14 more
Sep 15, 2022
Advanced Cancer, Pleural Effusion Trial in Houston (Intrapleural catheter (IPC) drained, IPC Placement, Chest X-Ray)
Active, not recruiting
- Advanced Cancer
- Pleural Effusion
- Intrapleural catheter (IPC) drained
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 24, 2022
Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of
Recruiting
- Advanced Cancer
- +6 more
- Dose escalation: COM902 monotherapy.
- +3 more
-
Grand Rapids, Michigan
- +5 more
Aug 8, 2022
Measuring Sleep Disturbance Among Cancer Patients
Completed
- Advanced Cancer
- Questionnaire
- Actigraph
-
Houston, Texas
- +1 more
Jul 12, 2022
Advanced Cancer, Anorexia, Weight Loss Trial in Houston (Mirtazapine, Placebo)
Suspended
- Advanced Cancer
- +3 more
- Mirtazapine
- Placebo
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 26, 2022
Advanced Cancer, Metastatic Cancer, Malignant Tumor of Colon Trial in United States (MRTX849, BI 1701963)
Active, not recruiting
- Advanced Cancer
- +4 more
- MRTX849
- BI 1701963
-
Saint Louis, Missouri
- +3 more
Apr 4, 2022